Literature DB >> 30258155

Immunotherapy offers a promising bet against brain cancer.

Michael Eisenstein.   

Abstract

Entities:  

Keywords:  Brain; Cancer; Neuroscience; Therapeutics

Mesh:

Substances:

Year:  2018        PMID: 30258155     DOI: 10.1038/d41586-018-06705-6

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Authors:  Annick Desjardins; Matthias Gromeier; James E Herndon; Nike Beaubier; Dani P Bolognesi; Allan H Friedman; Henry S Friedman; Frances McSherry; Andrea M Muscat; Smita Nair; Katherine B Peters; Dina Randazzo; John H Sampson; Gordana Vlahovic; William T Harrison; Roger E McLendon; David Ashley; Darell D Bigner
Journal:  N Engl J Med       Date:  2018-06-26       Impact factor: 91.245

2.  Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.

Authors:  Michael C Brown; Eda K Holl; David Boczkowski; Elena Dobrikova; Mubeen Mosaheb; Vidya Chandramohan; Darell D Bigner; Matthias Gromeier; Smita K Nair
Journal:  Sci Transl Med       Date:  2017-09-20       Impact factor: 17.956

3.  Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Authors:  Kristen A Batich; Elizabeth A Reap; Gary E Archer; Luis Sanchez-Perez; Smita K Nair; Robert J Schmittling; Pam Norberg; Weihua Xie; James E Herndon; Patrick Healy; Roger E McLendon; Allan H Friedman; Henry S Friedman; Darell Bigner; Gordana Vlahovic; Duane A Mitchell; John H Sampson
Journal:  Clin Cancer Res       Date:  2017-04-15       Impact factor: 12.531

4.  A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

Authors:  Donald M O'Rourke; MacLean P Nasrallah; Arati Desai; Jan J Melenhorst; Keith Mansfield; Jennifer J D Morrissette; Maria Martinez-Lage; Steven Brem; Eileen Maloney; Angela Shen; Randi Isaacs; Suyash Mohan; Gabriela Plesa; Simon F Lacey; Jean-Marc Navenot; Zhaohui Zheng; Bruce L Levine; Hideho Okada; Carl H June; Jennifer L Brogdon; Marcela V Maus
Journal:  Sci Transl Med       Date:  2017-07-19       Impact factor: 17.956

5.  Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC.

Authors:  Timothy F Cloughesy; Joseph Landolfi; Michael A Vogelbaum; Derek Ostertag; James B Elder; Stephen Bloomfield; Bob Carter; Clark C Chen; Steven N Kalkanis; Santosh Kesari; Albert Lai; Ian Y Lee; Linda M Liau; Tom Mikkelsen; Phioanh Nghiemphu; David Piccioni; William Accomando; Oscar R Diago; Daniel J Hogan; Dawn Gammon; Noriyuki Kasahara; Thian Kheoh; Douglas J Jolly; Harry E Gruber; Asha Das; Tobias Walbert
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

6.  Structural and functional features of central nervous system lymphatic vessels.

Authors:  Antoine Louveau; Igor Smirnov; Timothy J Keyes; Jacob D Eccles; Sherin J Rouhani; J David Peske; Noel C Derecki; David Castle; James W Mandell; Kevin S Lee; Tajie H Harris; Jonathan Kipnis
Journal:  Nature       Date:  2015-06-01       Impact factor: 49.962

7.  First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Authors:  Linda M Liau; Keyoumars Ashkan; David D Tran; Jian L Campian; John E Trusheim; Charles S Cobbs; Jason A Heth; Michael Salacz; Sarah Taylor; Stacy D D'Andre; Fabio M Iwamoto; Edward J Dropcho; Yaron A Moshel; Kevin A Walter; Clement P Pillainayagam; Robert Aiken; Rekha Chaudhary; Samuel A Goldlust; Daniela A Bota; Paul Duic; Jai Grewal; Heinrich Elinzano; Steven A Toms; Kevin O Lillehei; Tom Mikkelsen; Tobias Walbert; Steven R Abram; Andrew J Brenner; Steven Brem; Matthew G Ewend; Simon Khagi; Jana Portnow; Lyndon J Kim; William G Loudon; Reid C Thompson; David E Avigan; Karen L Fink; Francois J Geoffroy; Scott Lindhorst; Jose Lutzky; Andrew E Sloan; Gabriele Schackert; Dietmar Krex; Hans-Jorg Meisel; Julian Wu; Raphael P Davis; Christopher Duma; Arnold B Etame; David Mathieu; Santosh Kesari; David Piccioni; Manfred Westphal; David S Baskin; Pamela Z New; Michel Lacroix; Sven-Axel May; Timothy J Pluard; Victor Tse; Richard M Green; John L Villano; Michael Pearlman; Kevin Petrecca; Michael Schulder; Lynne P Taylor; Anthony E Maida; Robert M Prins; Timothy F Cloughesy; Paul Mulholland; Marnix L Bosch
Journal:  J Transl Med       Date:  2018-05-29       Impact factor: 5.531

  7 in total
  5 in total

1.  Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype.

Authors:  Adam M Swartz; Kelly M Hotchkiss; Smita K Nair; John H Sampson; Kristen A Batich
Journal:  Methods Mol Biol       Date:  2022

2.  Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways.

Authors:  Xiangqi Meng; Yu Zhao; Bo Han; Caijun Zha; Yangong Zhang; Ziwei Li; Pengfei Wu; Tengfei Qi; Chuanlu Jiang; Yang Liu; Jinquan Cai
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

3.  Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.

Authors:  Xiaoning Lin; Rong Huang; Yanlin Huang; Kai Wang; Heng Li; Yiheng Bao; Chaohui Wu; Yi Zhang; Xinhua Tian; Xiaomin Wang
Journal:  Int J Nanomedicine       Date:  2021-03-05

Review 4.  Modeling of radiation effects to immune system: a review.

Authors:  Wonmo Sung; Byungchul Cho
Journal:  J Korean Phys Soc       Date:  2022-08-08       Impact factor: 0.657

Review 5.  Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.

Authors:  Syreeta DeCordova; Abhishek Shastri; Anthony G Tsolaki; Hadida Yasmin; Lukas Klein; Shiv K Singh; Uday Kishore
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.